
Dimeji Lanade/X
Jul 7, 2025, 06:15
Dimeji Lanade: MSS Tumors in Lynch Syndrome and Better Understanding Response to Immunotherapy
Dimeji Lanade, Hematology/Oncology Fellow at Atrium Health, shared on X:
“MSS tumors in lynch syndrome and better understanding response to immunotherapy
MSI-H vs MSS Tumors in Lynch Syndrome -Are there patient and disease distinctions between the two? Our study suggested so!
Thanks ESMO.”
MORE POSTS FEATURING ESMOGI25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 7, 2025, 05:48
Jul 7, 2025, 05:32
Jul 6, 2025, 19:46
Jul 6, 2025, 19:33
Jul 6, 2025, 18:44